tirzepatide by eli lilly releases Zepbound® (tirzepatide) single-dose vials, expanding supply and access for adults living with obesity Eli Lilly's weight loss drug

The measurement of regional large artery stiffness should be expanded in the future for pathomechanistic studies via a multimodal vascular imaging approach in combination with vascular biomarkers (e.g., extracellular vesicles, blood biomarkers for inflammation, and endothelial dysfunction)

Severe (Rare): Acute pancreatitis, severe gallbladder disease (cholecystitis), or acute kidney injury caused by dehydration from severe GI side effects

The decision stems from positive results of the FLOW trial, which examined risk reduction from Ozempic therapy in chronic kidney disease (CKD)-related events

Applicable Procedure Codes: 62263, 62264, 62290, 62291, 62292, 64999, 72285, 72295

Only medication acquisition costs were included in the analysisthe costs of diabetes-related complications were not included, as these would not be expected to differ over the 1-year time horizon, and neither micro- nor macrovascular complications were assessed in SUSTAIN 2 or SUSTAIN 7